| D002123 |
Calcium Dobesilate |
A drug used to reduce hemorrhage in diabetic retinopathy. |
Dobesilate Calcium,2,5-Dihydroxybenzenesulfonate,2,5-Dihydroxybenzenesulfonic Acid,Calcium Dobesilate (1:1),Calcium Dobesilate Monoammonium Salt,Calcium Dobesilate Monopotassium Salt,Dexium,Dobica,Doxium,2,5 Dihydroxybenzenesulfonate,2,5 Dihydroxybenzenesulfonic Acid,Calcium, Dobesilate,Dobesilate, Calcium |
|
| D003930 |
Diabetic Retinopathy |
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. |
Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic |
|
| D004341 |
Drug Evaluation |
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. |
Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000293 |
Adolescent |
A person 13 to 18 years of age. |
Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths |
|
| D000328 |
Adult |
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. |
Adults |
|
| D001557 |
Benzenesulfonates |
Organic salts and esters of benzenesulfonic acid. |
|
|